Search Results for: netter 1

Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS

AAA today announced that quality of life findings from the pivotal NETTER-1 Phase III study investigating the treatment of Lutetium Lu 177 Dotatate in patients with somatostatin receptor positive midgut neuroendocrine tumors (midgut NETs) will be presented at the 14th Annual Conference of the Europe...

Advanced Accelerator Applications Announces New England Journal of Medicine Publication of NETTER-1 Phase III Results

AAA today announced that the New England Journal of Medicine published the results of the NETTER-1 Phase III study evaluating 177Lutetium Dotatate, an investigational drug, in patients with advanced, progressive somatostatin receptor-positive midgut neuroendocrine tumors (“NETs”). ...

Advanced Accelerator Applications Announces Presentations on Lutathera® NETTER-1 Phase III and NeoBOMB1 at EANM

AAA today announced that data from the pivotal NETTER-1 Phase III study investigating the treatment of Lutathera® (lutetium Lu 177 dotatate) in patients with somatostatin receptor positive midgut neuroendocrine tumors (midgut NETs) and preclinical oncology studies with NeoBOMB1, a novel GRPR antago...

New Data Presented for AAA’s Lutathera NETTER-1 Phase 3 Study at 2016 Gastrointestinal Cancer Symposium ASCO GI.

AAA today presented new safety and efficacy data from the pivotal Phase 3 NETTER-1 study investigating the treatment of Lutathera (177-Lu-Dotatate) in patients with inoperable, progressive, somatostatin receptor positive midgut neuroendocrine tumors (midgut NETs) at the 2016 Gastrointestinal Cancer ...

Advanced Accelerator Applications to Present New Data from Lutathera NETTER-1 Phase 3 Study at 2016 Gastrointestinal Cancer Symposium (ASCO GI)

AAA today announced that new safety and efficacy data from the pivotal Phase 3 NETTER-1 study investigating the treatment of Lutathera (177-Lu-Dotatate) in patients with inoperable, progressive, somatostatin receptor positive midgut neuroendocrine tumors (midgut NETs) will be presented on Friday, Ja...